Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP.

Am J Psychiatry. 1998 Mar;155(3):367-72.

PMID:
9501747
2.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
3.

Paroxetine in the treatment of depression: a comparison with imipramine and placebo.

Feighner JP, Boyer WF.

J Clin Psychiatry. 1992 Feb;53 Suppl:44-7.

PMID:
1531824
4.
5.

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD.

Am J Psychiatry. 2001 Jun;158(6):906-12.

PMID:
11384898
6.

A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.

Feighner JP.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:31-5.

PMID:
1431008
7.

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72.

8.

A double-blind comparison of paroxetine, imipramine, and placebo in major depression.

Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.

J Clin Psychiatry. 1992 Feb;53 Suppl:48-51.

PMID:
1531825
9.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
10.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
11.

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.

J Clin Psychiatry. 2002 Jul;63(7):577-84.

PMID:
12143913
12.

Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.

Chiu HJ, Hong CJ, Chan CH.

Zhonghua Yi Xue Za Zhi (Taipei). 1996 Jun;57(6):418-23.

PMID:
8803304
13.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
14.

A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.

McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF.

Am J Psychiatry. 2000 Mar;157(3):344-50.

PMID:
10698808
15.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
16.

Gender differences in treatment response to sertraline versus imipramine in chronic depression.

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.

Am J Psychiatry. 2000 Sep;157(9):1445-52.

PMID:
10964861
17.

A placebo- and imipramine-controlled study of paroxetine.

Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.

Psychopharmacol Bull. 1990;26(2):185-9.

PMID:
2146697
18.

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

Rickels K, Zaninelli R, McCafferty J, Bellew K, Iyengar M, Sheehan D.

Am J Psychiatry. 2003 Apr;160(4):749-56.

PMID:
12668365
19.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
20.

A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.

Arminen SL, Ikonen U, Pulkkinen P, Leinonen E, Mahlanen A, Koponen H, Kourula K, Ryyppö J, Korpela V, Lehtonen ML, et al.

Acta Psychiatr Scand. 1994 Jun;89(6):382-9.

PMID:
8085467
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk